跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
POLYCITRA-K - Health Canada Drug Approval Details
Approvals
/
Health Canada
/
POLYCITRA-K
Authorized
STANDARD
POLYCITRA-K
Alza Corporation
🇨🇦 Health Canada
Approval Date
Jul 4, 2025
Approval ID
52ec63e0a4256a20
Company
Alza Corporation
Type
Standard
Approval Details
Approval Id
52ec63e0a4256a20
Drug Approval Canada Name
POLYCITRA-K
Product Name
POLYCITRA-K
Status
Cancelled Post Market
Status Date
2001-08-01
Original Market Date
1996-12-31
Din
02163241
Drug Class
Human
Dosage Form
Powder
Route Of Administration
Oral
Schedule
Ethical
Ahfs
40:12.00
Atc Original
A12BA02 POTASSIUM CITRATE
Atc Name
a 12 ba 02
Aig Number
0106894012
Company Name
Alza Corporation
Company Address
1900 Charleston Road, Mountain View, California, United States, 94043-7210
Company Detail Path
/organization/alza-corporation
Company Information
Pharmaceutical Company Name
Alza Corporation
Country Name
United States
Province Name
California
City Name
vacaville,california,country_us
Address
700 Eubanks Dr
Active Ingredients
POTASSIUM (POTASSIUM CITRATE)
1.193 G / 4.5 G
Authorized
Quick Info
Agency
Health Canada
Country
🇨🇦
Approval Date
Jul 4, 2025
Approval ID
52ec63e0a4256a20
Type
Standard
Back to Health Canada Approvals